442 related articles for article (PubMed ID: 30098778)
21. Decreased expression of hsa_circ_0072387 as a valuable predictor for oral squamous cell carcinoma.
Dou Z; Li S; Ren W; Wang Q; Liu J; Kong X; Gao L; Zhi K
Oral Dis; 2019 Jul; 25(5):1302-1308. PubMed ID: 30908839
[TBL] [Abstract][Full Text] [Related]
22. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
23. The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patients.
Ries J; Baran C; Wehrhan F; Weber M; Motel C; Kesting M; Nkenke E
Cancer Biomark; 2019; 24(1):19-30. PubMed ID: 30594916
[TBL] [Abstract][Full Text] [Related]
24. Alterations in miRNA expression patterns in whole blood of OSCC patients.
Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the current MicroRNAs expression levels as potential biomarkers in Oral Squamous Cell Carcinoma.
Tahmasebi E; Kaboudanian Ardestani A; Madihi N; Abbasiparashkouh Z; Abbasi Maleki S; Yazdanian M; Khafaei M; Movafagh A; Tavallaie M
Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):193-198. PubMed ID: 37114250
[TBL] [Abstract][Full Text] [Related]
27. A panel of microRNAs can be used to determine oral squamous cell carcinoma.
Prasad G; Seers C; Reynolds E; McCullough MJ
J Oral Pathol Med; 2017 Nov; 46(10):940-948. PubMed ID: 28512746
[TBL] [Abstract][Full Text] [Related]
28. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
Ries J; Vairaktaris E; Agaimy A; Kintopp R; Baran C; Neukam FW; Nkenke E
Oncol Rep; 2014 Mar; 31(3):1429-36. PubMed ID: 24452363
[TBL] [Abstract][Full Text] [Related]
29. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
30. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Expression Profiling in Adrenal Myelolipoma.
Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
[TBL] [Abstract][Full Text] [Related]
32. miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
Chamorro Petronacci CM; Pérez-Sayáns M; Padín Iruegas ME; Suárez Peñaranda JM; Lorenzo Pouso AI; Blanco Carrión A; García García A
Medicine (Baltimore); 2019 Mar; 98(13):e14922. PubMed ID: 30921188
[TBL] [Abstract][Full Text] [Related]
33. Profiling salivary miRNA expression levels in Fanconi anemia patients - a pilot study.
Tang KD; Amenábar JM; Schussel JL; Torres-Pereira CC; Bonfim C; Dimitrova N; Hartel G; Punyadeera C
Odontology; 2024 Jan; 112(1):299-308. PubMed ID: 37458838
[TBL] [Abstract][Full Text] [Related]
34. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinoma.
Moratin J; Hartmann S; Brands RC; Horn D; Fuchs A; Mutzbauer G; Seher A; Scholz C; Müller-Richter UDA; Linz C
J Craniomaxillofac Surg; 2019 Mar; 47(3):523-529. PubMed ID: 30709758
[TBL] [Abstract][Full Text] [Related]
37. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
38. PTEN and miR-26b: Promising prognostic biomarkers in initiation and progression of Oral Squamous Cell Carcinoma.
Baghaei F; Abdollahi A; Mohammadpour H; Jahanbin M; Naseri Taheri F; Aminishakib P; Emami Razavi A; Kharazifard M
J Oral Pathol Med; 2019 Jan; 48(1):31-35. PubMed ID: 30372795
[TBL] [Abstract][Full Text] [Related]
39. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
Wang X; Li F; Zhou X
Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
[TBL] [Abstract][Full Text] [Related]
40. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma.
Rajan C; Roshan VGD; Khan I; Manasa VG; Himal I; Kattoor J; Thomas S; Kondaiah P; Kannan S
Sci Rep; 2021 Mar; 11(1):7298. PubMed ID: 33790326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]